42 related articles for article (PubMed ID: 12194569)
1. Comparison of perimetric 24-2 and 30-2 test patterns in detecting visual field defects in patients with tumours in the pituitary region.
Gesslein B; Naumovska M; Neumann O; Bizios D; Bengtsson B; Siesjö P; Uvelius E; Hammar B; Sheikh R
Acta Ophthalmol; 2024 May; 102(3):326-333. PubMed ID: 37452447
[TBL] [Abstract][Full Text] [Related]
2. Inferior temporal quadrantanopia associated with pituitary adenomas and a potential mechanism of excessive optic nerve bending.
Demura M; Sasagawa Y; Hayashi Y; Tachibana O; Nakada M
Surg Neurol Int; 2024; 15():70. PubMed ID: 38468671
[TBL] [Abstract][Full Text] [Related]
3. Primary visual cortical thickness in correlation with visual field defects in patients with pituitary macroadenomas: a structural 7-Tesla retinotopic analysis.
Rutland JW; Delman BN; Huang KH; Verma G; Benson NC; Villavisanis DF; Lin HM; Bederson JB; Chelnis J; Shrivastava RK; Balchandani P
J Neurosurg; 2019 Oct; 133(5):1371-1381. PubMed ID: 31628280
[TBL] [Abstract][Full Text] [Related]
4. Visual acuity and pattern of visual field loss at presentation in pituitary adenoma.
Ogra S; Nichols AD; Stylli S; Kaye AH; Savino PJ; Danesh-Meyer HV
J Clin Neurosci; 2014 May; 21(5):735-40. PubMed ID: 24656736
[TBL] [Abstract][Full Text] [Related]
5. The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011.
Tjörnstrand A; Gunnarsson K; Evert M; Holmberg E; Ragnarsson O; Rosén T; Filipsson Nyström H
Eur J Endocrinol; 2014 Oct; 171(4):519-26. PubMed ID: 25084775
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of retinal nerve fibre layer thickness for postoperative visual improvement in patients with pituitary macroadenoma.
Kurian DE; V R; Horo S; Chacko AG; Prabhu K; Mahasampath G; Korah S
BMJ Open Ophthalmol; 2022 Jul; 7(1):. PubMed ID: 36161840
[TBL] [Abstract][Full Text] [Related]
7. Pituitary Adenomas: From Diagnosis to Therapeutics.
Banskota S; Adamson DC
Biomedicines; 2021 Apr; 9(5):. PubMed ID: 33946142
[TBL] [Abstract][Full Text] [Related]
8. Using sellar region tumor's size as a predictor of psychophysical and electrophysiological perimetric visual losses: a logistic regression approach.
Lobão CAF; Miquilini L; da Silva BSR; da Silva VGR; Lacerda EMDCB; Rosa AAM; Souza GDS
Doc Ophthalmol; 2019 Dec; 139(3):235-245. PubMed ID: 31338649
[TBL] [Abstract][Full Text] [Related]
9. Compressive Lesions of the Optic Chiasm: Subjective Symptoms and Visual Field Diagnostic Criteria.
Takahashi M; Goseki T; Ishikawa H; Hiroyasu G; Hirasawa K; Shoji N
Neuroophthalmology; 2018 Dec; 42(6):343-348. PubMed ID: 30524487
[TBL] [Abstract][Full Text] [Related]
10. Association of Ki-67 Labelling Index and IL-17A with Pituitary Adenoma.
Glebauskiene B; Liutkeviciene R; Vilkeviciute A; Gudinaviciene I; Rocyte A; Simonaviciute D; Mazetyte R; Kriauciuniene L; Zaliuniene D
Biomed Res Int; 2018; 2018():7490585. PubMed ID: 29955610
[TBL] [Abstract][Full Text] [Related]
11. Diagnosing pituitary adenoma in unstained sections based on multiphoton microscopy.
Lin P; Liu X; Wang S; Li X; Song Y; Li L; Cai S; Wang X; Chen J
Pituitary; 2018 Aug; 21(4):362-370. PubMed ID: 29594837
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and ophthalmologic findings of pituitary adenoma in Korean patients.
Kim TG; Jin KH; Kang J
Int Ophthalmol; 2019 Jan; 39(1):21-31. PubMed ID: 29274021
[TBL] [Abstract][Full Text] [Related]
13. Association of
Glebauskiene B; Vilkeviciute A; Liutkeviciene R; Jakstiene S; Kriauciuniene L; Zemaitiene R; Zaliuniene D
Oncol Lett; 2017 May; 13(5):3087-3099. PubMed ID: 28521414
[TBL] [Abstract][Full Text] [Related]
14. Role of MMP-2 (-1306 C/T) Polymorphism in Pituitary Adenoma.
Glebauskiene B; Liutkeviciene R; Vilkeviciute A; Kriauciuniene L; Bernotas G; Tamasauskas A; Zaliuniene D
Scientifica (Cairo); 2016; 2016():2839697. PubMed ID: 27051552
[TBL] [Abstract][Full Text] [Related]
15. The influence of pituitary adenoma size on vision and visual outcomes after trans-sphenoidal adenectomy: a report of 78 cases.
Ho RW; Huang HM; Ho JT
J Korean Neurosurg Soc; 2015 Jan; 57(1):23-31. PubMed ID: 25674340
[TBL] [Abstract][Full Text] [Related]
16. Visual field defects in 23 acromegalic patients.
Kan E; Kan EK; Atmaca A; Atmaca H; Colak R
Int Ophthalmol; 2013 Oct; 33(5):521-5. PubMed ID: 23397103
[TBL] [Abstract][Full Text] [Related]
17. Visual Fields at Presentation and after Trans-sphenoidal Resection of Pituitary Adenomas.
Dhasmana R; Nagpal RC; Sharma R; Bansal KK; Bahadur H
J Ophthalmic Vis Res; 2011 Jul; 6(3):187-91. PubMed ID: 22454734
[TBL] [Abstract][Full Text] [Related]
18. The volume of tumor mass and visual field defect in patients with pituitary macroadenoma.
Lee JP; Park IW; Chung YS
Korean J Ophthalmol; 2011 Feb; 25(1):37-41. PubMed ID: 21350693
[TBL] [Abstract][Full Text] [Related]
19. Visual field defects in non-functioning pituitary adenomas.
Thomas R; Shenoy K; Seshadri MS; Muliyil J; Rao A; Paul P
Indian J Ophthalmol; 2002 Jun; 50(2):127-30. PubMed ID: 12194569
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
